Big Pharma insists on sending carcinogen-contaminated pills to the public
Jan 17, 2020
Salon – Big Pharma spends a small fortune every year buying politicians to make sure we can’t import prescription drugs from Canada, but they’re more than happy to sell us contaminated medications from countries with weak manufacturing controls and exploitable labor that ensure high profit margins.
A toxic compound that doesn’t belong anywhere near medicine known as NDMA was first discovered in some blood pressure medications in 2018, and the FDA issued an alert and wrote a complaint letter to the raw materials supplier to Big Pharma companies.
It turns out the meds follow the very common pattern of being made in India with raw ingredients coming from China. And they are sold by big companies for obscenely high prices to U.S. consumers.
More recently, NDMA contamination provoked a nationwide recall of the popular anti-heartburn medication Zantac and all its generic versions.
And now the world’s most widely prescribed drug of all, which is used to treat and prevent Type 2 diabetes called metformin, is contaminated with NDMA.
NDMA (N-Nitrosodimethylamine) is, according to the World Health Organization, produced by “the degradation of dimethylhydrazine (a component of rocket fuel) as well as from several other industrial processes. It is also a contaminant of certain pesticides.”
And it’s one of the world’s most potent carcinogens, at least for humans and other mammals.
Our livers produce an enzyme that converts it to methyldiazonium that then leads to O6-methylguanine, both of which alter a process at the cellular level called methylation that is a cancer turbocharger.
Because it’s such a potent biological agent, NDMA is also extremely poisonous; a Chinese medical student put a few drops in his roommate’s water and killed him.
Ditto for a Canadian grad student, who injected it into a colleague’s apple pie. Read more.